AlgoScient Logo
Previously IDS Capital UK ltd, AlgoScient is a family investment company located in Luxembourg, rooted in the chemical, biopharmaceutical, and investment management industries. We collaborate with seasoned specialists worldwide across all asset classes. Our primary objective is to achieve long term attractive returns while prudently managing investment risk. We participate in both liquid markets and private investments.

Over its history, the firm has among others advised and invested in more than 500 hedge funds at all stages of development, in private equity and VC funds in multiple sectors and regions, structured specific access vehicles for various investment strategies in multiple jurisdictions and forms.
Industry Role:
InvestorAllocator
Investor Type:
SingleFamilyOffice
Investment Interests:
HedgeFund
PrivateEquity
# Location Address
1. Geneva, Geneva, CH Geneva, Switzerland
2. Leudelange, Esch-sur-Alzette, LU Leudelange, Luxembourg
# Contact Info Location
1.
Anthony Martin
CEO of the Swiss branch
                                                                Experienced Managing Director with a demonstrated history of working in the capital markets industry. Strong finance professional skilled in Trading, Market Risk and Quantitative Finance. 
                                                 
View Profile
    Geneva, Geneva, CH
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.